Skip to main content
. Author manuscript; available in PMC: 2008 Jun 26.
Published in final edited form as: Biochemistry. 2007 Nov 29;46(51):15089–15102. doi: 10.1021/bi7018783

Table 4.

ADP Reversal of Inhibition of the Various Compoundsa

compound [drug] (µM) activation (%) Kact ADP (µM) R2
no drug 21 (1.3) 17 (6.2) 0.88
GW5074 4 21 (9.4) 449 (411) 0.71
GW5074 8 34 (2.0) 31 (9.2) 0.90
hexachlorophene 3 92 (4.4) 89 (15) 0.97
ATA 8 207 (17) 222 (49) 0.96
bithionol 10 164 (4.7) 51 (6.2) 0.98
BSB 15 79 (1.8) 41 (32) 0.99
BH3I 10 140 (5.9) 34 (7.0) 0.95
DES 8 64 (2.0) 19 (3.4) 0.96
a

Shown here is a summary of the data shown in Figure 9, fitted to eq 6.